BrightSpring Health Services (NASDAQ:BTSG) Stock Price Expected to Rise, Guggenheim Analyst Says

BrightSpring Health Services (NASDAQ:BTSG) had its price objective boosted by equities research analysts at Guggenheim from $81.00 to $84.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim‘s price objective would suggest a potential upside of 25.41% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. Weiss Ratings upgraded shares of BrightSpring Health Services from a “hold (c+)” rating to a “buy (b)” rating in a research note on Monday. Wall Street Zen raised shares of BrightSpring Health Services from a “buy” rating to a “strong-buy” rating in a research report on Saturday. KeyCorp restated an “overweight” rating on shares of BrightSpring Health Services in a research note on Monday, August 3rd. UBS Group lifted their price target on shares of BrightSpring Health Services from $85.00 to $92.00 and gave the stock a “buy” rating in a report on Monday. Finally, Raymond James Financial initiated coverage on BrightSpring Health Services in a research report on Thursday, July 9th. They set an “outperform” rating and a $80.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $77.81.

BrightSpring Health Services Price Performance

BTSG opened at $66.98 on Tuesday. The firm has a market capitalization of $13.25 billion, a PE ratio of 36.04, a price-to-earnings-growth ratio of 0.77 and a beta of 1.87. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.59 and a quick ratio of 1.22. The business’s 50-day moving average is $60.09 and its two-hundred day moving average is $54.68. BrightSpring Health Services has a 1 year low of $30.64 and a 1 year high of $73.75.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings results on Friday, October 30th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. BrightSpring Health Services had a net margin of 2.55% and a return on equity of 16.73%. The business had revenue of $4.21 billion during the quarter, compared to analyst estimates of $3.88 billion. The firm’s revenue was up 26.4% on a year-over-year basis. Research analysts anticipate that BrightSpring Health Services will post 1.64 earnings per share for the current fiscal year.

Institutional Investors Weigh In On BrightSpring Health Services

Large investors have recently modified their holdings of the business. The Manufacturers Life Insurance Company purchased a new position in shares of BrightSpring Health Services in the 2nd quarter valued at approximately $239,377,000. Bank of America Corp DE acquired a new stake in BrightSpring Health Services in the 2nd quarter worth approximately $127,475,000. Bank of New York Mellon Corp acquired a new stake in BrightSpring Health Services in the 2nd quarter worth approximately $118,162,000. Arrowstreet Capital Limited Partnership boosted its stake in BrightSpring Health Services by 109.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,370,440 shares of the company’s stock worth $58,394,000 after purchasing an additional 716,949 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in BrightSpring Health Services by 236.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 860,134 shares of the company’s stock worth $36,151,000 after purchasing an additional 604,232 shares during the last quarter.

Key BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: UBS raised its price target to $92 from $85 and maintained a Buy rating, reinforcing the bullish analyst outlook. UBS raises BrightSpring price target
• Positive Sentiment: Leerink Partners lifted its target to $92 from $72 and upgraded its rating to Outperform, citing substantial potential upside from current levels. Leerink Partners BrightSpring rating
• Positive Sentiment: TD Cowen raised its target to $84 from $81 and assigned a Buy rating, while Wells Fargo increased its target to $82 from $78 and kept an Overweight rating. TD Cowen BrightSpring rating Wells Fargo BrightSpring rating
• Positive Sentiment: Third-quarter earnings reportedly beat expectations, with earnings up sharply as specialty pharmacy launches and home-health growth drove revenue gains, margin expansion and higher full-year guidance. Management also highlighted organic-growth opportunities for 2027. BrightSpring Q3 earnings beat
• Positive Sentiment: Wall Street Zen upgraded BrightSpring to Strong-Buy, adding to the series of positive analyst actions. Wall Street Zen BrightSpring upgrade
• Neutral Sentiment: At roughly 35.8 times earnings, BTSG is priced for continued execution. Its elevated beta also suggests potentially greater volatility as investors digest the earnings-driven rally.
• Negative Sentiment: With multiple price-target increases already reflected in recent strength, near-term profit-taking may be limiting further gains despite the favorable fundamental and analyst news.

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.